A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer
TBX2驱动的信号通路从雄激素受体向糖皮质激素受体的转换赋予前列腺癌治疗耐药性。
期刊:Oncogene
影响因子:6.9
doi:10.1038/s41388-024-03252-5
Sayanika Dutta ,Hamed Khedmatgozar ,Girijesh Kumar Patel ,Daniel Latour ,Jonathan Welsh ,Mainak Mustafi ,Antonina Mitrofanova ,Manisha Tripathi ,Srinivas Nandana
肿瘤
肿瘤免疫
信号转导
治疗耐药
TBX2
前列腺癌
免疫/内分泌
